Drug Profile
Iodine I 131 derlotuximab biotin
Alternative Names: 131-I chTNT 1/B; 131-I-chTNT-1/B mAb; Cotara; Iodine-131 radiolabelled TNT monoclonal antibody; Monoclonal antibody TNT-1; TNT-1; Tumour necrosis therapy-1Latest Information Update: 09 Aug 2021
Price :
$50
*
At a glance
- Originator Peregrine Pharmaceuticals
- Developer Avid Bioservices; MediPharm Biotech
- Class Antineoplastics; Iodine radioisotopes; Monoclonal antibodies; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Marketed Lung cancer
- Phase II Glioblastoma